Found 72 matching trials
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC PHASE2 This phase II trial compares the effect of adding radiation therapy to the ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma. PHASE1 This study is a prospective open-label, single-arm, single-center clinical ...
Show More Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer PHASE2 To evaluate the efficacy and safety of Serplulimab in combination with Tras...
Show More Location
the First Affiliated Hospital of the Air Force Medical University
Learn More & Join Trial
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer PHASE3 The goal of this clinical trial is to find out if adding a PD-1 antibody (s...
Show More Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma PHASE2 China with high incidence of esophageal cancer, the number of new cases and...
Show More Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer PHASE2 This study is a single-arm, multicenter, Phase II study to evaluate the eff...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer PHASE4 To evaluate the efficacy and safety of immune checkpoint inhibitor-based co...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma PHASE2 To evaluate the clinical efficacy of perioperative treatment with S-1 + oxa...
Show More Location
Chiba Cancer Center
Learn More & Join Trial
Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer PHASE2 Lung cancer remains a leading cause of cancer-related deaths worldwide, wit...
Show More Location
Multiple Locations
Learn More & Join Trial